Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-16

Clinical Trial Update: Trial of an Inactivated Yellow Fever Virus Vaccine [Phase 1]

View source ↗

Summary

Phase 1 study of an inactivated yellow fever vaccine sponsored by Najit Technologies; the trial is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Najit Technologies, Inc. | Conditions: Yellow Fever | Phase 1 | Status: COMPLETED | Results posted: 2024-05-16